Back to Journals » Transplant Research and Risk Management » Volume 2

Moving towards implementation of a clinical ethics consultation program in Egyptian liver transplant units

Authors El-Elemi A, El-Gazzaz G

Published 16 March 2010 Volume 2010:2 Pages 23—27

DOI https://doi.org/10.2147/TRRM.S8439

Review by Single anonymous peer review

Peer reviewer comments 4



A H El-Elemi1, G H El-Gazzaz2

1Forensic Medicine and Clinical Toxicology Department, 2Hepatobiliary and General Surgery Department, Suez Canal University, Ismailia, Egypt

Abstract: The high prevalence of chronic liver disease in Egypt has led to increasing numbers of patients with end-stage liver disease in need of liver transplantation. To date, cadaveric liver transplantation is not legal in Egypt. However, introducing living-donor liver transplantation seems appropriate for patients who need transplantation. There are no clinical bioethicists in the Egyptian healthcare system. The idea of implementing an ethics consultation program has evolved as a response to complicated legal, ethical, and social dilemmas that accompany the transplantation process, especially in Egypt where organs are obtained by advertising without consideration of an acceptable level of risk to donors or recipients. Recommendations need to be made to start to implement peoples who do bioethics consultation in liver transplantation units. To achieve this goal there is a need to develop training standards, credentials, and certification before embarking on clinical consultation to ensure good ethics practice in Egypt.

Keywords: live donor, liver transplantation, bioethics, donor, recipient

Creative Commons License © 2010 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.